Cargando…

A new paradigm evaluating cost per cure of HCV infection in the UK

BACKGROUND: New interferon (IFN)-free treatments for hepatitis C are more effective, safer but more expensive than current IFN-based therapies. Comparative data of these, versus current first generation protease inhibitors (PI) with regard to costs and treatment outcomes are needed. We investigated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barclay, Stephen T., Cooke, Graham S., Holtham, Elizabeth, Gauthier, Aline, Schwarzbard, Jeremie, Atanasov, Petar, Irving, William L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5898515/ https://www.ncbi.nlm.nih.gov/pubmed/30288304 http://dx.doi.org/10.1186/s41124-016-0002-z

Ejemplares similares

Cohort Profile: The Hepatitis C Virus (HCV) Research UK Clinical Database and Biobank
por: McLauchlan, J, et al.
Publicado: (2017)

Performance of models to predict hepatocellular carcinoma risk among UK patients with cirrhosis and cured HCV infection
por: Innes, Hamish, et al.
Publicado: (2021)

HCV cure without interferon
por: Bourlière, Marc
Publicado: (2014)

The cost-effectiveness of an HCV outreach intervention for at-risk populations in London, UK
por: Ward, Zoe, et al.
Publicado: (2019)

HCV cure for everyone or which challenges remain?
por: Rockstroh, Jürgen Kurt
Publicado: (2015)

Sofosbuvir, a Significant Paradigm Change in HCV Treatment
por: McQuaid, Thomas, et al.
Publicado: (2015)

Comparing the cost-per-QALYs gained and cost-per-DALYs averted literatures
por: Neumann, Peter J., et al.
Publicado: (2018)

HCV Cure With Direct-Acting Antivirals Improves Liver and Immunological Markers in HIV/HCV-Coinfected Patients
por: Brochado-Kith, Óscar, et al.
Publicado: (2021)

Need to Face Liver Cirrhosis after HCV Cure with Antivirals
por: Soriano, Vicente, et al.
Publicado: (2017)

Persistence of Cryoglobulinemic Vasculitis after DAA Induced HCV Cure
por: Danishwar, Mahmood, et al.
Publicado: (2022)

Memories of Stress: The Imprinted Cancer Risk After HCV Cure
por: Lupberger, Joachim, et al.
Publicado: (2023)

Aneurism of the Brachial Artery Cured by Injection of Per Chloride of Iron
por: LaGrange, M.
Publicado: (1857)

HCV microelimination in harm reduction centres has benefits beyond HCV cure but is hampered by high reinfection rates
por: Lens, Sabela, et al.
Publicado: (2022)

The Cost of Nursing per Bed
Publicado: (1909)

Clinical and economic benefits of a new paradigm of HCV diagnosis and treatment
por: Fagiuoli, Stefano, et al.
Publicado: (2021)

Liver Abnormalities after Elimination of HCV Infection: Persistent Epigenetic and Immunological Perturbations Post-Cure
por: Polyak, Stephen J., et al.
Publicado: (2021)

HCV kinetic and modeling analyses project shorter durations to cure under combined therapy with daclatasvir and asunaprevir in chronic HCV-infected patients
por: Canini, Laetitia, et al.
Publicado: (2017)

Indirect costs associated with ulcerative colitis: a systematic literature review of real-world data
por: Constantin, Joelle, et al.
Publicado: (2019)

Lymphocyte Landscape after Chronic Hepatitis C Virus (HCV) Cure: The New Normal
por: Ghosh, Alip, et al.
Publicado: (2020)

An examination of periodontal treatment and per member per month (PMPM) medical costs in an insured population
por: Albert, David A, et al.
Publicado: (2006)

Application of Ice in the Cure of Sciatica
por: Irving, James
Publicado: (1868)

Hepatitis virus (HCV) diagnosis and access to treatment in a UK cohort
por: Adland, Emily, et al.
Publicado: (2018)

The positive impact of self-compassion on disordered eating and associated risk factors
por: Holtham, Tiegan, et al.
Publicado: (2014)

Curing cancer? Further along the new pH-centric road and paradigm
por: Harguindey, S., et al.
Publicado: (2018)

933. Cured vs. Not Yet Treated: Population Differences for HIV/HCV Co-infected Patients Navigating the HCV Care Cascade in 11 Connecticut Clinics
por: Brooks, Ralph P, et al.
Publicado: (2020)

Direct-Acting Antivirals Improve Access to Care and Cure for Patients With HIV and Chronic HCV Infection
por: Collins, Lauren F, et al.
Publicado: (2017)

Determinants of per diem Hospital Costs in Mental Health
por: Wolff, Jan, et al.
Publicado: (2016)

Cost per responder of TNF-α therapies in Germany
por: Gissel, Christian, et al.
Publicado: (2013)

Trent HCV study: mortality rates and ethnic differences in outcome
por: Irving, W.L.
Publicado: (2006)

Heterologous Immunity between Adenoviruses and Hepatitis C Virus: A New Paradigm in HCV Immunity and Vaccines
por: Singh, Shakti, et al.
Publicado: (2016)

Five-Year Follow-Up of Cured HCV Patients under Real-World Interferon-Free Therapy
por: Flisiak, Robert, et al.
Publicado: (2021)

Severe liver fibrosis in the HCV cure era: Major effects of social vulnerability, diabetes, and unhealthy behaviors
por: Carrieri, Patrizia, et al.
Publicado: (2022)

Long-Term Persistence of Mitochondrial DNA Instability among HCV-Cured People Who Inject Drugs
por: Durand, Mélusine, et al.
Publicado: (2022)

Accounting for the relationship between per diem cost and LOS when estimating hospitalization costs
por: Ishak, K Jack, et al.
Publicado: (2012)

A Systematic Review of Cost-Effectiveness Studies Reporting Cost-per-DALY Averted
por: Neumann, Peter J., et al.
Publicado: (2016)

Cost comparisons and factors related to cost per stay in intensive care units in Belgium
por: Bruyneel, Arnaud, et al.
Publicado: (2023)

Lives Per Gallon: The True Cost of Our Oil Addiction
por: Preuss, Peter W.
Publicado: (2007)

Hospital Reconstruction and Rebuilding: Cost per Bed for Building Alone
Publicado: (1919)

Is the Cost per Occupied Bed the Only Criterion of Efficency and Economy?
Publicado: (1920)

Reducing the costs per patient by increasing the volume of cataract surgery
por: Malcolm, Jonathan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_49ub2l4tl5rk58cmt2c8uc3p7h